| NCT01882816 |
Intensity-Modulated Radiation Therapy (IMRT) in the Treatment of Non-Anaplastic Non-Medullary Thyroid Cancer |
https://ClinicalTrials.gov/show/NCT01882816 |
Active, not recruiting |
Memorial Sloan Kettering Cancer Center |
2021-06-30 |
| NCT01141309 |
Evaluating the Combination of Everolimus and Sorafenib in the Treatment of Thyroid Cancer |
https://ClinicalTrials.gov/show/NCT01141309 |
Active, not recruiting |
Memorial Sloan Kettering Cancer Center |
2021-06-30 |
| NCT04211337 |
A Study of Selpercatinib (LY3527723) in Participants With RET-Mutant Medullary Thyroid Cancer |
https://ClinicalTrials.gov/show/NCT04211337 |
Recruiting |
Eli Lilly and Company |
2023-02-17 |
| NCT04129411 |
Treatment of Papillary Thyroid Carcinoma With Radiofrequency Ablation |
https://ClinicalTrials.gov/show/NCT04129411 |
Recruiting |
Mayo Clinic |
2022-03-31 |
| NCT03469011 |
A Study to Try to Bring Back Radioiodine Sensitivity in Patients With Advanced Thyroid Cancer. |
https://ClinicalTrials.gov/show/NCT03469011 |
Recruiting |
AHS Cancer Control Alberta |
2020-12-31 |
| NCT03463889 |
Gallium-68 Prostate Specific Membrane Antigen PET in Diagnosing Patients With Thyroid Cancer |
https://ClinicalTrials.gov/show/NCT03463889 |
Recruiting |
University of California, San Francisco |
2021-12-31 |
| NCT03359668 |
CT Detection of Metastatic Lymphadenopathy in Papillary Thyroid Cancer |
https://ClinicalTrials.gov/show/NCT03359668 |
Completed |
University Health Network, Toronto |
2017-04-20 |
| NCT03377829 |
A Multicenter Trial of PLA vs. Surgery for Treating PTMC |
https://ClinicalTrials.gov/show/NCT03377829 |
Recruiting |
Ruijin Hospital |
2020-12-31 |
| NCT03360890 |
Pembrolizumab With Chemotherapy for Poorly Chemo-responsive Thyroid and Salivary Gland Tumors |
https://ClinicalTrials.gov/show/NCT03360890 |
Recruiting |
University of Chicago |
2020-06-30 |
| NCT03274258 |
Phase II Trial of Nivolumab Plus Ipilimumab in Patients With Renal Medullary Carcinoma |
https://ClinicalTrials.gov/show/NCT03274258 |
Recruiting |
M.D. Anderson Cancer Center |
2020-07-01 |
| NCT03246958 |
Nivolumab Plus Ipilimumab in Thyroid Cancer |
https://ClinicalTrials.gov/show/NCT03246958 |
Recruiting |
Dana-Farber Cancer Institute |
2021-03-31 |
| NCT03244956 |
Efficacy of MEK (Trametinib) and BRAFV600E (Dabrafenib) Inhibitors With Radioactive Iodine (RAI) for the Treatment of Refractory Metastatic Differentiated Thyroid Cancer |
https://ClinicalTrials.gov/show/NCT03244956 |
Recruiting |
Gustave Roussy, Cancer Campus, Grand Paris |
2022-12-31 |
| NCT03215095 |
RAI Plus Immunotherapy for Recurrent/Metastatic Thyroid Cancers |
https://ClinicalTrials.gov/show/NCT03215095 |
Active, not recruiting |
Memorial Sloan Kettering Cancer Center |
2021-07-31 |
| NCT03211117 |
Pembrolizumab, Chemotherapy, and Radiation Therapy With or Without Surgery in Treating Patients With Anaplastic Thyroid Cancer |
https://ClinicalTrials.gov/show/NCT03211117 |
Completed |
Mayo Clinic |
2018-02-12 |
| NCT03181100 |
Atezolizumab With Chemotherapy in Treating Patients With Anaplastic or Poorly Differentiated Thyroid Cancer |
https://ClinicalTrials.gov/show/NCT03181100 |
Recruiting |
M.D. Anderson Cancer Center |
2023-07-27 |
| NCT03176485 |
Evaluation of Pathway Modulation by Raf, MEK, & Kinase Inhibitors |
https://ClinicalTrials.gov/show/NCT03176485 |
Completed |
University of Arizona |
2018-11-01 |
| NCT03174925 |
Ultrasound Elastography in Imaging Patients With Thyroid Nodules |
https://ClinicalTrials.gov/show/NCT03174925 |
Active, not recruiting |
Stanford University |
2020-08-15 |
| NCT03167385 |
Phase 2 Trial of Apatinib Mesylate in Locally Advanced/Metastatic Differentiated Thyroid Carcinoma |
https://ClinicalTrials.gov/show/NCT03167385 |
Recruiting |
Tianjin Medical University Cancer Institute and Hospital |
2019-01-31 |
| NCT03162627 |
Selumetinib and Olaparib in Solid Tumors |
https://ClinicalTrials.gov/show/NCT03162627 |
Recruiting |
M.D. Anderson Cancer Center |
2026-08-31 |
| NCT03139747 |
UPCC 36315 A Phase II Study Of Everolimus (RAD001) And Lenvatinib (E7080) In Patients With Metastatic Differentiated Thyroid Cancer Who Have Progressed on Lenvatinib Alone |
https://ClinicalTrials.gov/show/NCT03139747 |
Completed |
Abramson Cancer Center of the University of Pennsylvania |
2019-10-03 |
| NCT03127098 |
QUILT-3.040: ETBX-011 (Ad5 [E1-, E2b-]-CEA(6D)) Vaccine in Combination With ALT-803 (Super-agonist IL-15) in Subjects Having CEA-Expressing Cancer |
https://ClinicalTrials.gov/show/NCT03127098 |
Completed |
NantCell, Inc. |
2017-12-07 |
| NCT03122496 |
Immunotherapy and Stereotactic Body Radiotherapy (SBRT) for Metastatic Anaplastic Thyroid Cancer |
https://ClinicalTrials.gov/show/NCT03122496 |
Active, not recruiting |
Memorial Sloan Kettering Cancer Center |
2021-04-30 |
| NCT03109847 |
Metformin Hydrochloride in Mitigating Side Effects of Radioactive Iodine Treatment in Patients With Differentiated Thyroid Cancer |
https://ClinicalTrials.gov/show/NCT03109847 |
Recruiting |
Thomas Jefferson University |
2021-06-08 |
| NCT03099356 |
Cyclophosphamide and Sirolimus for the Treatment of Metastatic, RAI-refractory, Differentiated Thyroid Cancer |
https://ClinicalTrials.gov/show/NCT03099356 |
Recruiting |
University of Michigan Rogel Cancer Center |
2022-05-12 |
| NCT03093909 |
Study of Aerosol Gemcitabine in Patients With Solid Tumors and Pulmonary Metastases |
https://ClinicalTrials.gov/show/NCT03093909 |
Recruiting |
M.D. Anderson Cancer Center |
2021-11-30 |
| NCT03085056 |
Trametinib in Combination With Paclitaxel in the Treatment of Anaplastic Thyroid Cancer |
https://ClinicalTrials.gov/show/NCT03085056 |
Recruiting |
Memorial Sloan Kettering Cancer Center |
2021-09-30 |
| NCT03072160 |
Pembrolizumab in Recurrent or Metastatic Medullary Thyroid Cancer |
https://ClinicalTrials.gov/show/NCT03072160 |
Completed |
National Institutes of Health Clinical Center (CC) |
2019-11-22 |
| NCT03048877 |
Efficacy of Apatinib in Radioactive Iodine-refractory Differentiated Thyroid Cancer |
https://ClinicalTrials.gov/show/NCT03048877 |
Active, not recruiting |
Peking Union Medical College Hospital |
2020-07-31 |
| NCT03037385 |
Phase 1/2 Study of the Highly-selective RET Inhibitor, Pralsetinib (BLU-667), in Patients With Thyroid Cancer, Non-Small Cell Lung Cancer, and Other Advanced Solid Tumors |
https://ClinicalTrials.gov/show/NCT03037385 |
Recruiting |
Blueprint Medicines Corporation |
2021-12-31 |
| NCT03024151 |
The Effects of T4 Versus T4/T3 on Psychological Distress After Total Thyroidectomy in Thyroid Cancer Patients |
https://ClinicalTrials.gov/show/NCT03024151 |
Completed |
Inje University |
2017-11-30 |
| NCT03012620 |
Secured Access to Pembrolizumab for Patients With Selected Rare Cancer Types |
https://ClinicalTrials.gov/show/NCT03012620 |
Recruiting |
UNICANCER |
2023-01-31 |
| NCT02988817 |
Enapotamab Vedotin (HuMax-AXL-ADC) Safety Study in Patients With Solid Tumors |
https://ClinicalTrials.gov/show/NCT02988817 |
Recruiting |
Genmab |
2021-02-28 |
| NCT02973997 |
Lenvatinib and Pembrolizumab in DTC |
https://ClinicalTrials.gov/show/NCT02973997 |
Active, not recruiting |
Academic and Community Cancer Research United |
2021-10-08 |
| NCT02966093 |
A Trial of Lenvatinib (E7080) in Radioiodine (131 I)-Refractory Differentiated Thyroid Cancer in China |
https://ClinicalTrials.gov/show/NCT02966093 |
Active, not recruiting |
Eisai Inc. |
2019-07-31 |
| NCT02947035 |
Molecular Testing to Direct Extent of Initial Thyroid Surgery |
https://ClinicalTrials.gov/show/NCT02947035 |
Recruiting |
University of Pittsburgh |
2022-02-01 |
| NCT02878044 |
Shared Decision Making in Patients With Thyroid Nodules |
https://ClinicalTrials.gov/show/NCT02878044 |
Recruiting |
Mayo Clinic |
2021-04-30 |
| NCT02870569 |
Phase 2 Trial of Donafenib in 131I-Refractory Differentiated Thyroid Cancer |
https://ClinicalTrials.gov/show/NCT02870569 |
Completed |
Suzhou Zelgen Biopharmaceuticals Co.,Ltd |
2018-07-02 |
| NCT02856347 |
Prospective Study Evaluating the Medullary Thyroid Cancer Management’s Care Using PET F-DOPA in Patients With a High Level of Postoperative Residual Thyrocalcitonin |
https://ClinicalTrials.gov/show/NCT02856347 |
Recruiting |
Institut Claudius Regaud |
2021-04-30 |
| NCT02839655 |
Prospective Study Assessing Thyroidectomy Using Robot |
https://ClinicalTrials.gov/show/NCT02839655 |
Active, not recruiting |
Gustave Roussy, Cancer Campus, Grand Paris |
2018-05-15 |
| NCT02826746 |
Effect of Intravenous Magnesium on Postoperative Sore Throat After Thyroidectomy |
https://ClinicalTrials.gov/show/NCT02826746 |
Completed |
Ajou University School of Medicine |
2019-03-31 |
| NCT02758158 |
Tri-modal Imaging Instrument for Thyroid Cancer |
https://ClinicalTrials.gov/show/NCT02758158 |
Completed |
University Health Network, Toronto |
2017-02-28 |
| NCT02747888 |
Hereditary Risk Factors for Thyroid Cancer |
https://ClinicalTrials.gov/show/NCT02747888 |
Recruiting |
Dana-Farber Cancer Institute |
2021-03-01 |
| NCT02731352 |
Study of Apatinib in Patients With Differentiated Thyroid Cancer |
https://ClinicalTrials.gov/show/NCT02731352 |
Active, not recruiting |
Peking Union Medical College Hospital |
2020-02-27 |
| NCT02726503 |
Phase II Study Assessing the Efficacy and Safety of Lenvatinib for Anaplastic Thyroid Cancer |
https://ClinicalTrials.gov/show/NCT02726503 |
Completed |
Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan |
2020-02-25 |
| NCT02724176 |
Potential Role for Carbon Nanoparticles to Guide Central Neck Dissection in Patients With Papillary Thyroid Cancer |
https://ClinicalTrials.gov/show/NCT02724176 |
Completed |
Beijing Cancer Hospital |
2016-01-31 |
| NCT02713269 |
Thermal Ablation and Spine Stereotactic Radiosurgery in Treating Patients With Spine Metastases at Risk for Compressing the Spinal Cord |
https://ClinicalTrials.gov/show/NCT02713269 |
Recruiting |
M.D. Anderson Cancer Center |
2022-07-01 |
| NCT02688608 |
Pembrolizumab in Anaplastic/Undifferentiated Thyroid Cancer |
https://ClinicalTrials.gov/show/NCT02688608 |
Recruiting |
University of Texas Southwestern Medical Center |
2020-10-31 |
| NCT02657551 |
A Study Using Regorafenib as Second or Third Line Therapy in Metastatic Medullary Thyroid Cancer |
https://ClinicalTrials.gov/show/NCT02657551 |
Recruiting |
Dana-Farber Cancer Institute |
2020-12-31 |
| NCT02614495 |
Study of Sulfatinib in Treating Advanced Medullary Thyroid Carcinoma and Iodine-refractory Differentiated Thyroid Carcinoma |
https://ClinicalTrials.gov/show/NCT02614495 |
Completed |
Hutchison Medipharma Limited |
2018-09-30 |
| NCT02609685 |
Active Surveillance of Papillary Thyroid Microcarcinoma |
https://ClinicalTrials.gov/show/NCT02609685 |
Recruiting |
Cedars-Sinai Medical Center |
2030-12-31 |
| NCT02602717 |
The Evaluation of the Diagnostic Properties of Intra-operative In-situ Thyroglobin Levels of Cervical Lymph Nodes, in the Discrimination Between Benign and Malignant Lymph Nodes in Thyroid Cancer: a Prospective Multicentre Study. |
https://ClinicalTrials.gov/show/NCT02602717 |
Recruiting |
Assistance Publique Hopitaux De Marseille |
2017-05-17 |
| NCT02592356 |
Effect of Cabozantinib S-Malate or Lenvatinib Mesylate on Weight and Body Composition in Patients With Metastatic Endocrine Cancer |
https://ClinicalTrials.gov/show/NCT02592356 |
Active, not recruiting |
M.D. Anderson Cancer Center |
2020-11-30 |
| NCT02586350 |
Study of Anlotinib in Patients With Medullary Thyroid Carcinoma(ALTER01031) |
https://ClinicalTrials.gov/show/NCT02586350 |
Completed |
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. |
2018-09-30 |
| NCT02586337 |
Study of Anlotinib in Patients With Differentiated Thyroid Cancer(ALTER01032) |
https://ClinicalTrials.gov/show/NCT02586337 |
Active, not recruiting |
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. |
2019-12-31 |
| NCT02834013 |
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors |
https://ClinicalTrials.gov/show/NCT02834013 |
Recruiting |
National Cancer Institute (NCI) |
2021-08-31 |
| NCT01896479 |
A Study of Two Different Doses of Cabozantinib (XL184) in Progressive, Metastatic Medullary Thyroid Cancer |
https://ClinicalTrials.gov/show/NCT01896479 |
Active, not recruiting |
Exelixis |
2020-09-30 |
| NCT02465060 |
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial) |
https://ClinicalTrials.gov/show/NCT02465060 |
Recruiting |
National Cancer Institute (NCI) |
2022-06-30 |
| NCT02561533 |
Detection of BRAF Mutation on FNAB From Papillary Thyroid Carcinoma |
https://ClinicalTrials.gov/show/NCT02561533 |
Completed |
University of Aarhus |
2017-07-31 |
| NCT03196518 |
Study of PET Imaging With 18F-TFB in Patients With Thyroid Cancer |
https://ClinicalTrials.gov/show/NCT03196518 |
Recruiting |
Memorial Sloan Kettering Cancer Center |
2022-06-30 |
| NCT02515084 |
Comparison DW-MRI vs FDG PET/CT in the Detection of Early Recurrence of Cervical Well-differentiated Thyroid Carcinoma |
https://ClinicalTrials.gov/show/NCT02515084 |
Completed |
Centre Henri Becquerel |
2015-07-31 |
| NCT02464696 |
Early Non Invasive Ventilation and Hematological Malignancies |
https://ClinicalTrials.gov/show/NCT02464696 |
Recruiting |
M.D. Anderson Cancer Center |
2020-10-01 |
| NCT02456701 |
Enhancing Radioiodine Incorporation Into BRAF Mutant Thyroid Cancers With the Combination of Vemurafenib and KTN3379 |
https://ClinicalTrials.gov/show/NCT02456701 |
Completed |
Celldex Therapeutics |
2016-10-13 |
| NCT02418390 |
The Efficacy and Safety of Prophylactic Central Lymph Node Dissection in Papillary Thyroid Carcinoma |
https://ClinicalTrials.gov/show/NCT02418390 |
Recruiting |
Seoul National University Hospital |
2022-02-28 |
| NCT02418247 |
Minimize Radioactive Iodine Ablation Of Remnant Thyroid in Differentiated Thyroid Cancer |
https://ClinicalTrials.gov/show/NCT02418247 |
Active, not recruiting |
National Cancer Center, Korea |
2017-12-31 |
| NCT02412150 |
Effect of Dexmedetomidine After Thyroidectomy |
https://ClinicalTrials.gov/show/NCT02412150 |
Recruiting |
Chosun University Hospital |
2020-12-30 |
| NCT02408887 |
Total Thyroidectomy With and Without Prophylactic Central Neck Lymph Node Dissection in People With Low-risk Papillary Thyroid Cancer |
https://ClinicalTrials.gov/show/NCT02408887 |
Completed |
National Institutes of Health Clinical Center (CC) |
2019-05-07 |
| NCT02404441 |
Phase I/II Study of PDR001 in Patients With Advanced Malignancies |
https://ClinicalTrials.gov/show/NCT02404441 |
Active, not recruiting |
Novartis |
2020-07-01 |
| NCT02393690 |
Iodine I-131 With or Without Selumetinib in Treating Patients With Recurrent or Metastatic Thyroid Cancer |
https://ClinicalTrials.gov/show/NCT02393690 |
Active, not recruiting |
Academic and Community Cancer Research United |
2021-02-01 |
| NCT02390934 |
Efficacy of Radium 223 in Radioactive Iodine Refractory Bone Metastases From Differentiated Thyroid Cancer |
https://ClinicalTrials.gov/show/NCT02390934 |
Completed |
Gustave Roussy, Cancer Campus, Grand Paris |
2019-04-02 |
| NCT02383927 |
Phase II Study of Tipifarnib in Squamous Head and Neck Cancer With HRAS Mutations |
https://ClinicalTrials.gov/show/NCT02383927 |
Active, not recruiting |
Kura Oncology, Inc. |
2021-01-15 |
| NCT02363647 |
Personalized Cancer Therapy for Patients With Metastatic Medullary Thyroid or Metastatic Colon Cancer |
https://ClinicalTrials.gov/show/NCT02363647 |
Enrolling by invitation |
Icahn School of Medicine at Mount Sinai |
2020-01-31 |
| NCT02304757 |
99Tc-MDP in Postmenopausal Women With Differentiated Thyroid Cancer and Decreased Bone Mineral Density |
https://ClinicalTrials.gov/show/NCT02304757 |
Recruiting |
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine |
2020-06-30 |
| NCT02278198 |
Evaluation of Thyroid Stunning From a Diagnostic Dose of I-123 |
https://ClinicalTrials.gov/show/NCT02278198 |
Completed |
University of Colorado, Denver |
2019-09-20 |
| NCT02244463 |
A Phase II Study of MLN0128 in Metastatic Anaplastic Thyroid Cancer |
https://ClinicalTrials.gov/show/NCT02244463 |
Recruiting |
Dana-Farber Cancer Institute |
2020-12-31 |
| NCT02223052 |
Bioequivalence & Food Effect Study in Patients With Solid Tumor or Hematologic Malignancies |
https://ClinicalTrials.gov/show/NCT02223052 |
Completed |
Celgene |
2018-06-11 |
| NCT02208544 |
FDG-PET/CT in Evaluation of Cytological Indeterminate Thyroid Nodules to Prevent Unnecessary Surgery (EfFECTS) |
https://ClinicalTrials.gov/show/NCT02208544 |
Active, not recruiting |
Radboud University |
2020-07-01 |
| NCT02205801 |
Study of the Efficacy of Local Analgesia as an Adjunct to General Anesthesia in Thyroidectomy and Parathyroidectomy |
https://ClinicalTrials.gov/show/NCT02205801 |
Completed |
University of Chicago |
2017-02-10 |
| NCT02156362 |
Determination of Pronostics Factors for Advanced Thyroid Carcinoma (pT3 pT4 or M1 at Diagnosis) |
https://ClinicalTrials.gov/show/NCT02156362 |
Recruiting |
Hospices Civils de Lyon |
2023-05-31 |
| NCT02152995 |
Trametinib in Increasing Tumoral Iodine Incorporation in Patients With Recurrent or Metastatic Thyroid Cancer |
https://ClinicalTrials.gov/show/NCT02152995 |
Recruiting |
National Cancer Institute (NCI) |
2020-12-31 |
| NCT02152137 |
Inolitazone Dihydrochloride and Paclitaxel in Treating Patients With Advanced Anaplastic Thyroid Cancer |
https://ClinicalTrials.gov/show/NCT02152137 |
Active, not recruiting |
Alliance for Clinical Trials in Oncology |
2019-02-27 |
| NCT02145143 |
Enhancing Radioiodine (RAI) Incorporation Into BRAF Mutant, RAI-Refractory Thyroid Cancers With the BRAF Inhibitor Vemurafenib: A Pilot Study |
https://ClinicalTrials.gov/show/NCT02145143 |
Active, not recruiting |
Memorial Sloan Kettering Cancer Center |
2021-05-31 |
| NCT02143726 |
Sorafenib Tosylate With or Without Everolimus in Treating Patients With Advanced, Radioactive Iodine Refractory Hurthle Cell Thyroid Cancer |
https://ClinicalTrials.gov/show/NCT02143726 |
Active, not recruiting |
Alliance for Clinical Trials in Oncology |
2020-08-31 |
| NCT02138214 |
Central Neck Dissection in Patients With Clinical Node Negative Thyroid Cancer |
https://ClinicalTrials.gov/show/NCT02138214 |
Active, not recruiting |
University of Wisconsin, Madison |
2019-10-30 |
| NCT02114658 |
Sorafenib Phase II Study for Japanese Anaplastic or Medullary Thyroid Carcinoma Patients |
https://ClinicalTrials.gov/show/NCT02114658 |
Completed |
Bayer |
2015-02-23 |
| NCT02088645 |
177Lu-PP-F11N for Receptor Targeted Therapy and Imaging of Metastatic Thyroid Cancer. |
https://ClinicalTrials.gov/show/NCT02088645 |
Recruiting |
University Hospital, Basel, Switzerland |
2021-12-31 |
| NCT02084732 |
Safety and Efficacy of Sorafenib in Patients With Advanced Thyroid Cancer: a Phase II Clinical Study |
https://ClinicalTrials.gov/show/NCT02084732 |
Completed |
Instituto Nacional de Cancerologia, Columbia |
2019-11-01 |
| NCT01308320 |
Dose-dependent Effect of Fentanyl on Cough Attenuation During Emergence From General Anaesthesia |
https://ClinicalTrials.gov/show/NCT01308320 |
Completed |
Yonsei University |
2010-07-31 |
| NCT01298323 |
Study to Determine if Contacting Patients With MTC More Frequently Results in Earlier Detection and Treatment of Signs and Symptoms of AEs and Thus a Decrease in the Percentage of Time Patients Experience AEs During First 12 Months on Vandetanib Treatment |
https://ClinicalTrials.gov/show/NCT01298323 |
Active, not recruiting |
Sanofi |
2013-04-30 |
| NCT01292044 |
The Role of Elastography in the Diagnosis of Thyroid Nodules |
https://ClinicalTrials.gov/show/NCT01292044 |
Completed |
Centre Hospitalier Universitaire de NÄ«mes |
2014-08-31 |
| NCT01286753 |
A Study of Vemurafenib (RO5185426) in Participants With Metastatic or Unresectable Papillary Thyroid Cancer Positive for the BRAF V600 Mutation |
https://ClinicalTrials.gov/show/NCT01286753 |
Completed |
Hoffmann-La Roche |
2014-11-30 |
| NCT01270321 |
Pasireotide & Everolimus in Adult Patients With Radioiodine-Refractory Differentiated & Medullary Thyroid Cancer |
https://ClinicalTrials.gov/show/NCT01270321 |
Completed |
Emory University |
2019-02-28 |
| NCT02055989 |
A Phase I/II Study of the Use of Intensity Modulated Radiotherapy (IMRT) in Cancer of the Thyroid, Larynx and Hypopharynx |
https://ClinicalTrials.gov/show/NCT02055989 |
Completed |
Royal Marsden NHS Foundation Trust |
2011-12-31 |
| NCT02041260 |
A Phase II Trial of Cabozantinib for the Treatment of Radioiodine (RAI)-Refractory Differentiated Thyroid Carcinoma (DTC) in the First-line Setting |
https://ClinicalTrials.gov/show/NCT02041260 |
Active, not recruiting |
Abramson Cancer Center of the University of Pennsylvania |
2020-03-31 |
| NCT02018276 |
Effect of Perioperative Intravenous Lidocaine Infusion and Magnesium Infusion on the Functional Recovery After General Anesthesia in the Patients Undergoing Thyroid Surgery |
https://ClinicalTrials.gov/show/NCT02018276 |
Completed |
Yonsei University |
2014-10-31 |
| NCT02012686 |
The Effect of Transcutaneous Electrical Nerve Stimulation on Posterior Neck Pain After Thyroidectomy |
https://ClinicalTrials.gov/show/NCT02012686 |
Completed |
Yonsei University |
2014-01-31 |
| NCT01964144 |
An Open-label, Multicenter, Phase II Study of Dovitinib in Advanced Thyroid Cancer |
https://ClinicalTrials.gov/show/NCT01964144 |
Completed |
Yonsei University |
2014-10-31 |
| NCT01947023 |
Dabrafenib and Lapatinib in Treating Patients With Refractory Thyroid Cancer That Cannot Be Removed by Surgery |
https://ClinicalTrials.gov/show/NCT01947023 |
Active, not recruiting |
National Cancer Institute (NCI) |
2020-07-01 |
| NCT01927887 |
Pre-Operative Nodal Staging of Thyroid Cancer Using USPIO MRI: Preliminary Study |
https://ClinicalTrials.gov/show/NCT01927887 |
Completed |
Massachusetts General Hospital |
2015-04-30 |
| NCT01907997 |
Effects of Systemic Lidocaine on Postoperative Quality of Recovery After Robot-assisted Thyroidectomy |
https://ClinicalTrials.gov/show/NCT01907997 |
Completed |
Yonsei University |
2015-03-31 |
| NCT01856920 |
QUILT-3.006 for Recurrent Medullary Thyroid Cancer |
https://ClinicalTrials.gov/show/NCT01856920 |
Active, not recruiting |
NantCell, Inc. |
2019-12-31 |
| NCT01840332 |
Method of Endogenous TSH Stimulation in the Follow-up of Differentiated Thyroid Cancer |
https://ClinicalTrials.gov/show/NCT01840332 |
Completed |
University of Tartu |
2014-02-28 |
| NCT01837745 |
Differentiated Thyroid Cancer: is There a Need for Radioiodine Ablation in Low Risk Patients? |
https://ClinicalTrials.gov/show/NCT01837745 |
Recruiting |
Gustave Roussy, Cancer Campus, Grand Paris |
2020-04-30 |
| NCT01833650 |
The Use of Candy and Honey in Decreasing Salivary Gland Damage Following Radioiodine Therapy for Thyroid Cancer |
https://ClinicalTrials.gov/show/NCT01833650 |
Completed |
Cyprus University of Technology |
2018-08-31 |
| NCT01813136 |
Phase II Study of the Optimal Scheme of Administration of Pazopanib in Thyroid Carcinoma |
https://ClinicalTrials.gov/show/NCT01813136 |
Completed |
Centre Leon Berard |
2019-01-31 |
| NCT01811212 |
Cabozantinib-S-Malate in Treating Patients With Refractory Thyroid Cancer |
https://ClinicalTrials.gov/show/NCT01811212 |
Completed |
National Cancer Institute (NCI) |
2015-07-13 |
| NCT01788982 |
Nintedanib(BIBF1120) in Thyroid Cancer |
https://ClinicalTrials.gov/show/NCT01788982 |
Active, not recruiting |
European Organisation for Research and Treatment of Cancer - EORTC |
2019-10-31 |
| NCT01776385 |
The ISET (Isolation by Size of Epithelial Tumor Cells) and the CellSearch Methods in Malignant Pleural Mesothelioma |
https://ClinicalTrials.gov/show/NCT01776385 |
Completed |
Centre Hospitalier Universitaire de Nice |
2017-12-31 |
| NCT01730638 |
ImmunoTEP for Patients With Medullary Thyroid Carcinoma. |
https://ClinicalTrials.gov/show/NCT01730638 |
Completed |
Nantes University Hospital |
2016-12-31 |
| NCT01728623 |
A Study of E7080 in Subjects With Advanced Thyroid Cancer |
https://ClinicalTrials.gov/show/NCT01728623 |
Completed |
Eisai Inc. |
2015-07-31 |
| NCT01723202 |
Dabrafenib With or Without Trametinib in Treating Patients With Recurrent Thyroid Cancer |
https://ClinicalTrials.gov/show/NCT01723202 |
Active, not recruiting |
Ohio State University Comprehensive Cancer Center |
2020-12-31 |
| NCT01709435 |
Cabozantinib S-Malate in Treating Younger Patients With Recurrent or Refractory Solid Tumors |
https://ClinicalTrials.gov/show/NCT01709435 |
Completed |
National Cancer Institute (NCI) |
2018-12-31 |
| NCT01709292 |
Vemurafenib Neoadjuvant Trial in Locally Advanced Thyroid Cancer |
https://ClinicalTrials.gov/show/NCT01709292 |
Active, not recruiting |
M.D. Anderson Cancer Center |
2020-11-30 |
| NCT01661179 |
Evaluate the Safety and Tolerability of Vandetanib in Japanese Patients With Medullary Thyroid Carcinoma |
https://ClinicalTrials.gov/show/NCT01661179 |
Completed |
Sanofi |
2013-12-31 |
| NCT01655719 |
Pioglitazone in Thyroid Cancers |
https://ClinicalTrials.gov/show/NCT01655719 |
Completed |
University of Michigan |
2017-03-31 |
| NCT01638533 |
Romidepsin in Treating Patients With Lymphoma, Chronic Lymphocytic Leukemia, or Solid Tumors With Liver Dysfunction |
https://ClinicalTrials.gov/show/NCT01638533 |
Active, not recruiting |
National Cancer Institute (NCI) |
2018-11-29 |
| NCT01631552 |
Phase I/II Study of IMMU-132 in Patients With Epithelial Cancers |
https://ClinicalTrials.gov/show/NCT01631552 |
Active, not recruiting |
Immunomedics, Inc. |
2020-06-30 |
| NCT01625520 |
SOM230 Alone or in Combination With RAD001 in Patients With Medullary Thyroid Cancer |
https://ClinicalTrials.gov/show/NCT01625520 |
Completed |
Federico II University |
2016-03-31 |
| NCT01617694 |
Comparison Between Remifentanil Target-controlled Infusion and Dexmedetomidine Bolus Administration for Smooth Emergence From General Sevoflurane Anesthesia |
https://ClinicalTrials.gov/show/NCT01617694 |
Completed |
Yonsei University |
2011-11-30 |
| NCT01616316 |
Efficacy of Subfascial Approach in Thyroidectomy to Quality of Life in Thyroid Disease Patients |
https://ClinicalTrials.gov/show/NCT01616316 |
Completed |
Samsung Medical Center |
2012-01-31 |
| NCT01552434 |
Bevacizumab and Temsirolimus Alone or in Combination With Valproic Acid or Cetuximab in Treating Patients With Advanced or Metastatic Malignancy or Other Benign Disease |
https://ClinicalTrials.gov/show/NCT01552434 |
Recruiting |
M.D. Anderson Cancer Center |
2020-03-31 |
| NCT01534897 |
Re-differentiation of Radioiodine-Refractory BRAF V600E-mutant Papillary Thyroid Carcinoma With GSK2118436 |
https://ClinicalTrials.gov/show/NCT01534897 |
Completed |
Massachusetts General Hospital |
2014-03-31 |
| NCT01510002 |
Prophylactic Central Neck Dissection for Papillary Thyroid Cancer |
https://ClinicalTrials.gov/show/NCT01510002 |
Completed |
Jagiellonian University |
2011-09-30 |
| NCT01502410 |
Sorafenib Tosylate in Treating Younger Patients With Relapsed or Refractory Rhabdomyosarcoma, Wilms Tumor, Liver Cancer, or Thyroid Cancer |
https://ClinicalTrials.gov/show/NCT01502410 |
Completed |
National Cancer Institute (NCI) |
2014-06-30 |
| NCT01496313 |
To Compare The Effects Of Two Doses Of Vandetanib In Patients With Advanced Medullary Thyroid Cancer |
https://ClinicalTrials.gov/show/NCT01496313 |
Active, not recruiting |
Sanofi |
2014-04-30 |
| NCT01438554 |
Phase 1 Study of Pazopanib With GSK1120212 in Advanced Solid Tumors, Enriched With Patients With Differentiated Thyroid Cancer, Soft-tissue Sarcoma, and Cholangiocarcinoma |
https://ClinicalTrials.gov/show/NCT01438554 |
Completed |
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins |
2016-04-30 |
| NCT01437254 |
To Compare Safety and the General Imaging Pattern of Cyclotron Produced Technetium vs. Generator Produced Technetium in Patients With Thyroid Cancer |
https://ClinicalTrials.gov/show/NCT01437254 |
Completed |
AHS Cancer Control Alberta |
2012-04-30 |
| NCT01413113 |
Iodine I 131 and Pazopanib Hydrochloride in Treating Patients With Recurrent and/or Metastatic Thyroid Cancer Previously Treated With Iodine I 131 That Cannot Be Removed By Surgery |
https://ClinicalTrials.gov/show/NCT01413113 |
Completed |
University of Washington |
2013-11-30 |
| NCT01398085 |
IoN- Is Ablative Radio-iodine Necessary for Low Risk Differentiated Thyroid Cancer Patients |
https://ClinicalTrials.gov/show/NCT01398085 |
Recruiting |
University College, London |
2020-11-30 |
| NCT01341886 |
Effect of Metformin on Decrement in Levothyroxin Dose Required for Thyroid Stimulating Hormone (TSH) Suppression in Patients With Differentiated Thyroid Cancer |
https://ClinicalTrials.gov/show/NCT01341886 |
Completed |
Mashhad University of Medical Sciences |
2011-04-30 |
| NCT01325857 |
Analgesic Efficacy of Bilateral Superficial Cervical Plexus Block in Robot-assisted Endoscopic Thyroidectomy Using a Transaxillary Approach |
https://ClinicalTrials.gov/show/NCT01325857 |
Completed |
Yonsei University |
2012-02-29 |
| NCT01321554 |
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Trial of Lenvatinib (E7080) in 131I-Refractory Differentiated Thyroid Cancer (DTC) |
https://ClinicalTrials.gov/show/NCT01321554 |
Completed |
Eisai Inc. |
2013-11-15 |
| NCT04425512 |
Delta Neutrophil Index and Neutrophil Lymphocyte Ratio in Thyroid Malignancy |
https://ClinicalTrials.gov/show/NCT04425512 |
Completed |
Kahramanmaras Sutcu Imam University |
2019-11-01 |
| NCT04420689 |
A Study of ALM-488 to Highlight Nerves in Patients Undergoing Head & Neck Surgery |
https://ClinicalTrials.gov/show/NCT04420689 |
Recruiting |
Alume Biosciences, Inc. |
2020-12-31 |
| NCT04410601 |
Post-thyroidectomy Dysphagia: An International Multicentric CONSORT - Compatible RCT |
https://ClinicalTrials.gov/show/NCT04410601 |
Recruiting |
Umraniye Education and Research Hospital |
2021-06-30 |
| NCT04336696 |
Is Routine Dissection of Central Lymph Node Necessary for Papillary Thyroid Carcinoma, T1-2 N0? |
https://ClinicalTrials.gov/show/NCT04336696 |
Recruiting |
Zagazig University |
2020-04-03 |
| NCT04312087 |
Lateral Neck Lymph Node Mapping in Thyroid Cancer |
https://ClinicalTrials.gov/show/NCT04312087 |
Recruiting |
Fudan University |
2021-08-01 |
| NCT04309136 |
Anlotinib Neoadjuvant Treatment in Locally Advanced Thyroid Cancer |
https://ClinicalTrials.gov/show/NCT04309136 |
Recruiting |
Fudan University |
2021-06-01 |
| NCT04290663 |
Systematic Radioiodine Administration (3.7 GBq I131 After rhTSH) Versus Decision of Radioiodine Treatment Guided by a Post-operative Work-up |
https://ClinicalTrials.gov/show/NCT04290663 |
Recruiting |
Centre Francois Baclesse |
2026-02-28 |
| NCT04281875 |
Assessing Benefits of NIRAF Detection for Identifying Parathyroid Glands During Total Thyroidectomy. |
https://ClinicalTrials.gov/show/NCT04281875 |
Recruiting |
Vanderbilt-Ingram Cancer Center |
2021-03-31 |
| NCT04280081 |
A Study of Selpercatinib (LY3527723) in Participants With Advanced Solid Tumors Including RET Fusion-positive Solid Tumors, Medullary Thyroid Cancer and Other Tumors With RET Activation |
https://ClinicalTrials.gov/show/NCT04280081 |
Recruiting |
Eli Lilly and Company |
2021-05-31 |
| NCT04248166 |
Thyroid Cancer and Photoacoustic Imaging |
https://ClinicalTrials.gov/show/NCT04248166 |
Recruiting |
Seoul St. Mary’s Hospital |
2020-06-30 |
| NCT04238624 |
Study of Cemiplimab Combined With Dabrafenib and Trametinib in People With Anaplastic Thyroid Cancer |
https://ClinicalTrials.gov/show/NCT04238624 |
Recruiting |
Memorial Sloan Kettering Cancer Center |
2022-06-20 |
| NCT04180007 |
Study of Neoadjuvant Regimen for Radioactive Iodine Treatment of Metastatic and Advanced Differentiated Thyroid Cancers |
https://ClinicalTrials.gov/show/NCT04180007 |
Recruiting |
Nanjing First Hospital, Nanjing Medical University |
2020-04-10 |
| NCT04129281 |
Active Surveillance Versus Surgery in Thyroid Papillary Microcarcinoma |
https://ClinicalTrials.gov/show/NCT04129281 |
Recruiting |
National Cancer Institute, Naples |
2022-01-23 |
| NCT04104529 |
Clinico-biological Database in Patients Treated With Metabolic Radiotherapy in the Nuclear Medicine Department |
https://ClinicalTrials.gov/show/NCT04104529 |
Recruiting |
Institut du Cancer de Montpellier - Val d’Aurelle |
2024-10-31 |
| NCT03268785 |
Intra-operative Rapid Identification of Lymph Node and Parathyroid |
https://ClinicalTrials.gov/show/NCT03268785 |
Recruiting |
Xijing Hospital |
2018-08-01 |
| NCT03986593 |
Cryoablation of Bone Metastases From Endocrine Tumors |
https://ClinicalTrials.gov/show/NCT03986593 |
Recruiting |
Instituto do Cancer do Estado de São Paulo |
2021-06-15 |
| NCT03969108 |
Diagnostic Accuracy Study of Indocyanine Green for Parathyroid Perfusion Assessment |
https://ClinicalTrials.gov/show/NCT03969108 |
Completed |
University Health Network, Toronto |
2019-11-12 |
| NCT03914300 |
Testing the Combination of Cabozantinib, Nivolumab, and Ipilimumab (CaboNivoIpi) for Advanced Differentiated Thyroid Cancer |
https://ClinicalTrials.gov/show/NCT03914300 |
Recruiting |
National Cancer Institute (NCI) |
2021-01-15 |
| NCT03899792 |
A Study of Oral LOXO-292 in Pediatric Patients With Advanced Solid or Primary Central Nervous System Tumors |
https://ClinicalTrials.gov/show/NCT03899792 |
Recruiting |
Loxo Oncology, Inc. |
2021-11-30 |
| NCT03892993 |
Patient Decision Aid in Supporting Decision-Making About When to Start or Stop New Drugs, Join Clinical Trials, or Continue Active Surveillance in Patients With Medullary Thyroid Cancer and Their Caregivers |
https://ClinicalTrials.gov/show/NCT03892993 |
Recruiting |
M.D. Anderson Cancer Center |
2020-07-31 |
| NCT03845647 |
Significance of Contralateral Central Lymph Node Dissection in Unilateral cN0 Differentiated Thyroid Carcinoma. |
https://ClinicalTrials.gov/show/NCT03845647 |
Recruiting |
Fifth Affiliated Hospital, Sun Yat-Sen University |
2020-01-28 |
| NCT03841617 |
The Use of 124-I-PET/CT Whole Body and Lesional Dosimetry in Differentiated Thyroid Cancer |
https://ClinicalTrials.gov/show/NCT03841617 |
Recruiting |
National Institutes of Health Clinical Center (CC) |
2024-02-01 |
| NCT03830242 |
Diagnostic Significance of FDG PET/CT Dynamic Imaging in Detecting Metastatic Lymph Nodes With Papillary Thyroid Cancer. |
https://ClinicalTrials.gov/show/NCT03830242 |
Recruiting |
Fifth Affiliated Hospital, Sun Yat-Sen University |
2019-12-31 |
| NCT03826680 |
Modified Cormack Lehane Scores Evaluated by Laryngoscopy During Awake Versus Under General Anesthesia |
https://ClinicalTrials.gov/show/NCT03826680 |
Recruiting |
Istanbul University |
2020-06-30 |
| NCT03808779 |
A Multicenter Trial of Radiofrequency Ablation vs. Surgery as Treatment of Papillary Thyroid Microcarcinoma. |
https://ClinicalTrials.gov/show/NCT03808779 |
Recruiting |
Second Affiliated Hospital, School of Medicine, Zhejiang University |
2024-02-01 |
| NCT03794375 |
Primary Care Transfer for Thyroid Cancer Patients |
https://ClinicalTrials.gov/show/NCT03794375 |
Enrolling by invitation |
Hospital de Clinicas de Porto Alegre |
2020-12-31 |
| NCT03757637 |
Compare the Effects of NLSCP and Interactive ICT Supported HAP on Differentiate Diagnosed Thyroid Cancer Patients |
https://ClinicalTrials.gov/show/NCT03757637 |
Recruiting |
National Taiwan University Hospital |
2021-07-31 |
| NCT03753919 |
Durvalumab Plus Tremelimumab for the Treatment of Patients With Progressive, Refractory Advanced Thyroid Carcinoma -The DUTHY Trial |
https://ClinicalTrials.gov/show/NCT03753919 |
Recruiting |
Grupo Espanol de Tumores Neuroendocrinos |
2020-12-31 |
| NCT03732495 |
Study of the Efficacy of Lenvatinib Combined With Denosumab in the Treatment of Patients With Predominant Bone Metastatic Radioiodine Refractory Differentiated Thyroid Carcinomas |
https://ClinicalTrials.gov/show/NCT03732495 |
Recruiting |
Centre Leon Berard |
2021-12-15 |
| NCT03690388 |
A Study of Cabozantinib Compared With Placebo in Subjects With Radioiodine-refractory Differentiated Thyroid Cancer Who Have Progressed After Prior VEGFR-targeted Therapy |
https://ClinicalTrials.gov/show/NCT03690388 |
Recruiting |
Exelixis |
2020-07-31 |
| NCT03680222 |
Effect of Reversed Tracking Method for Identification of EBSLN in Thyroid Surgery |
https://ClinicalTrials.gov/show/NCT03680222 |
Recruiting |
Fujian Medical University |
2019-09-30 |
| NCT03647657 |
177Lu-PP-F11N in Combination With Sacubitril for Receptor Targeted Therapy and Imaging of Metastatic Thyroid Cancer |
https://ClinicalTrials.gov/show/NCT03647657 |
Recruiting |
University Hospital, Basel, Switzerland |
2020-06-30 |
| NCT03647358 |
Lesion Dosimetry With Iodine-124 in Metastatic Thyroid Carcinoma |
https://ClinicalTrials.gov/show/NCT03647358 |
Recruiting |
Memorial Sloan Kettering Cancer Center |
2022-08-31 |
| NCT03630120 |
Adaptive Tyrosine Kinase Inhibitor (TKI) Therapy In Patients With Thyroid Cancer |
https://ClinicalTrials.gov/show/NCT03630120 |
Active, not recruiting |
H. Lee Moffitt Cancer Center and Research Institute |
2020-12-31 |
| NCT03602495 |
Donafenib in 131I-Refractory Differentiated Thyroid Cancer |
https://ClinicalTrials.gov/show/NCT03602495 |
Recruiting |
Suzhou Zelgen Biopharmaceuticals Co.,Ltd |
2020-12-31 |
| NCT03577951 |
Comparing the Establishment of Operation Space Between High Position and Low Position in Endoscopic Thyroid Surgery |
https://ClinicalTrials.gov/show/NCT03577951 |
Recruiting |
Fujian Medical University |
2018-08-31 |
| NCT03573960 |
A Study to Evaluate the Safety and Efficacy of Lenvatinib in Participants With Refractory Differentiated Thyroid Cancer |
https://ClinicalTrials.gov/show/NCT03573960 |
Recruiting |
Eisai Inc. |
2020-06-01 |
| NCT03547648 |
Effect of Three Different Peak Airway Pressures on Determining Intraoperative Bleeding in Thryroidectomies |
https://ClinicalTrials.gov/show/NCT03547648 |
Completed |
Istanbul University |
2018-11-16 |
| NCT03530033 |
Lidocaine Reduces Muscle Tremor is Beneficial for Intraoperative Recurrent Laryngeal Nerve Monitoring |
https://ClinicalTrials.gov/show/NCT03530033 |
Recruiting |
Fujian Medical University |
2018-10-31 |
| NCT03517579 |
Personalized Treatment in Thyroid Disorders |
https://ClinicalTrials.gov/show/NCT03517579 |
Recruiting |
Johns Hopkins University |
2020-10-15 |
| NCT03506048 |
Lenvatinib and Iodine Therapy in Treating Patients With Radioactive Iodine-Sensitive Differentiated Thyroid Cancer |
https://ClinicalTrials.gov/show/NCT03506048 |
Recruiting |
Emory University |
2021-01-31 |
| NCT03484416 |
Routine Calcium for Preventing Hypocalcemia |
https://ClinicalTrials.gov/show/NCT03484416 |
Completed |
Ewha Womans University Mokdong Hospital |
2017-05-30 |
| NCT03470259 |
Precision Thyroid Cancer Surgery With Molecular Fluorescent Guided Imaging |
https://ClinicalTrials.gov/show/NCT03470259 |
Completed |
University Medical Center Groningen |
2019-12-31 |
| NCT03469310 |
Minimizing Narcotic Analgesics After Endocrine Surgery |
https://ClinicalTrials.gov/show/NCT03469310 |
Active, not recruiting |
Doctors Hospital at Renaissance |
2019-12-21 |
| NCT02112370 |
Efficacy of Ropivacaine (With Epinephrine) in BABA Endoscopic and Robotic Thyroidectomy |
https://ClinicalTrials.gov/show/NCT02112370 |
Completed |
Seoul National University Hospital |
2016-05-31 |
| NCT03454477 |
Comparison Between Robotic, Endoscopic and Traditional Open Surgery in Thyroidectomy |
https://ClinicalTrials.gov/show/NCT03454477 |
Recruiting |
Fujian Medical University |
2018-10-01 |
| NCT03454464 |
Evaluation of Central Compartment Dissection Without Thyroidectomy |
https://ClinicalTrials.gov/show/NCT03454464 |
Recruiting |
Fujian Medical University |
2018-12-31 |
| NCT03435952 |
Pembrolizumab With Intratumoral Injection of Clostridium Novyi-NT |
https://ClinicalTrials.gov/show/NCT03435952 |
Recruiting |
M.D. Anderson Cancer Center |
2021-10-31 |
| NCT03432299 |
Radiofrequency Ablation of Low Risk Papillary Thyroid Microcarcinoma |
https://ClinicalTrials.gov/show/NCT03432299 |
Recruiting |
Seoul National University Hospital |
2020-11-27 |
| NCT03420963 |
Ex-Vivo Expanded Allogeneic NK Cells For The Treatment Of Pediatric Solid Tumors |
https://ClinicalTrials.gov/show/NCT03420963 |
Recruiting |
M.D. Anderson Cancer Center |
2022-12-01 |
| NCT03411187 |
Study on the Application of Convenient Foot-control Exhaust Method in Endoscopic Thyroidectomy |
https://ClinicalTrials.gov/show/NCT03411187 |
Recruiting |
Fujian Medical University |
2018-06-30 |
| NCT01263951 |
Study of Everolimus and Sorafenib in Patients With Advanced Thyroid Cancer Who Progressed on Sorafenib Alone |
https://ClinicalTrials.gov/show/NCT01263951 |
Completed |
Abramson Cancer Center of the University of Pennsylvania |
2018-12-31 |
| NCT04462471 |
Vemurafenib Plus Copanlisib in Radioiodine-Refractory (RAIR) Thyroid Cancers |
https://ClinicalTrials.gov/show/NCT04462471 |
Recruiting |
Memorial Sloan Kettering Cancer Center |
2022-06-30 |
| NCT01240590 |
A Phase I/II Trial of Crolibulin (EPC2407) Plus Cisplatin in Adults With Solid Tumors With a Focus on Anaplastic Thyroid Cancer (ATC) |
https://ClinicalTrials.gov/show/NCT01240590 |
Completed |
National Institutes of Health Clinical Center (CC) |
2015-08-31 |
| NCT01236547 |
Intensity-Modulated Radiation Therapy and Paclitaxel With or Without Pazopanib Hydrochloride in Treating Patients With Anaplastic Thyroid Cancer |
https://ClinicalTrials.gov/show/NCT01236547 |
Active, not recruiting |
National Cancer Institute (NCI) |
2020-03-09 |
| NCT01229865 |
Safety and Efficacy of VB-111 in Subjects With Advanced Differentiated Thyroid Cancer |
https://ClinicalTrials.gov/show/NCT01229865 |
Completed |
Vascular Biogenics Ltd. operating as VBL Therapeutics |
2014-10-31 |
| NCT01226914 |
A Trial Comparing Wound Drainage and Post-operative Complications With and Without the Use of EVICELâ„¢ Fibrin Sealant in Thyroidectomy |
https://ClinicalTrials.gov/show/NCT01226914 |
Completed |
Medical University of South Carolina |
2014-07-31 |
| NCT01208051 |
Cediranib Maleate With or Without Lenalidomide for the Treatment of Thyroid Cancer |
https://ClinicalTrials.gov/show/NCT01208051 |
Active, not recruiting |
National Cancer Institute (NCI) |
2020-02-01 |
| NCT01182285 |
A Phase II Trial of Valproic Acid in Patients With Advanced Thyroid Cancers of Follicular Cell Origin |
https://ClinicalTrials.gov/show/NCT01182285 |
Completed |
National Institutes of Health Clinical Center (CC) |
2015-09-28 |
| NCT01173289 |
Study of External Beam Radiotherapy to Thyroid Carcinoma |
https://ClinicalTrials.gov/show/NCT01173289 |
Completed |
National Cancer Center, Korea |
2015-08-31 |
| NCT01164176 |
Everolimus in Treating Patients With Locally Advanced or Metastatic Thyroid Cancer |
https://ClinicalTrials.gov/show/NCT01164176 |
Completed |
Yonsei University |
2014-10-31 |
| NCT01150318 |
Testicular Function After Iodine 131 Therapy in Papillary Carcinoma Patients |
https://ClinicalTrials.gov/show/NCT01150318 |
Completed |
Assistance Publique - Hôpitaux de Paris |
2010-06-30 |
| NCT01137097 |
Lateral Neck Sentinel Lymph Node Biopsy(LSLNB)in PTC |
https://ClinicalTrials.gov/show/NCT01137097 |
Completed |
Samsung Medical Center |
2011-01-31 |
| NCT01126060 |
Efficacy of Fibrin Sealant to Reduce the Amount of Post-thyroidectomy Drain |
https://ClinicalTrials.gov/show/NCT01126060 |
Completed |
Samsung Medical Center |
2011-01-31 |
| NCT01103557 |
Prophylactic Selective Lateral Neck Dissection in Patients With Papillary Thyroid Carcinoma |
https://ClinicalTrials.gov/show/NCT01103557 |
Completed |
Pusan National University Hospital |
NA |
| NCT01100619 |
A Drug-Drug Interaction Study of the Effects of XL184 (Cabozantinib) on Rosiglitazone in Subjects With Solid Tumors |
https://ClinicalTrials.gov/show/NCT01100619 |
Completed |
Exelixis |
2012-08-31 |
| NCT01083550 |
Decision Making on Radioactive Iodine Treatment for Papillary Thyroid Cancer |
https://ClinicalTrials.gov/show/NCT01083550 |
Completed |
University Health Network, Toronto |
2016-11-30 |
| NCT03871387 |
The Effects of Deep Neuromuscular Blockade During Robot-assisted Transaxillary Thyroidectomy on Postoperative Pain and Sensory Change |
https://ClinicalTrials.gov/show/NCT03871387 |
Completed |
Yonsei University |
2020-02-24 |
| NCT01025453 |
Combination of Temsirolimus and Sorafenib in the Treatment of Radioactive Iodine Refractory Thyroid Cancer |
https://ClinicalTrials.gov/show/NCT01025453 |
Completed |
Memorial Sloan Kettering Cancer Center |
2018-01-16 |
| NCT01013597 |
Trial of LBH589 in Metastatic Thyroid Cancer |
https://ClinicalTrials.gov/show/NCT01013597 |
Completed |
University of Wisconsin, Madison |
2013-08-31 |
| NCT00984282 |
Nexavar® Versus Placebo in Locally Advanced/Metastatic RAI-Refractory Differentiated Thyroid Cancer |
https://ClinicalTrials.gov/show/NCT00984282 |
Completed |
Bayer |
2012-08-31 |
| NCT00970359 |
Reacquisition of Radioactive Iodine (RAI) Uptake of RAI-Refractory Metastatic Thyroid Cancers by Pretreatment With the Selective MEK Inhibitor AZD6244 |
https://ClinicalTrials.gov/show/NCT00970359 |
Completed |
Memorial Sloan Kettering Cancer Center |
2013-04-30 |
| NCT00936858 |
RAD001 for Patients With Radioiodine Refractory Thyroid Cancer |
https://ClinicalTrials.gov/show/NCT00936858 |
Completed |
Dana-Farber Cancer Institute |
2020-02-27 |
| NCT00887107 |
Sorafenib as Adjuvant to Radioiodine Therapy in Non-Medullary Thyroid Carcinoma |
https://ClinicalTrials.gov/show/NCT00887107 |
Completed |
Leiden University Medical Center |
NA |
| NCT04424485 |
Near-infrared Fluorescence With Indocyanine Green for Identification of Sentinels and Parathyroids During Thyroidectomy |
https://ClinicalTrials.gov/show/NCT04424485 |
Recruiting |
Umraniye Education and Research Hospital |
2021-06-01 |
| NCT03375931 |
The Effects of Preoperative Prayer on Postoperative Quality of Recovery in Patients Undergoing Thyroidectomy |
https://ClinicalTrials.gov/show/NCT03375931 |
Recruiting |
Yonsei University |
2020-05-31 |
| NCT01876784 |
Evaluation of Efficacy, Safety of Vandetanib in Patients With Differentiated Thyroid Cancer |
https://ClinicalTrials.gov/show/NCT01876784 |
Active, not recruiting |
Sanofi |
2015-08-30 |
| NCT01539655 |
Study in Healthy Volunteers to Assess Effect of Omeprazole and Ranitidine on the Pharmacokinetics of Vandetanib |
https://ClinicalTrials.gov/show/NCT01539655 |
Completed |
Sanofi |
2012-09-30 |
| NCT04161391 |
Study of TPX-0046, A RET/SRC Inhibitor in Adult Subjects With Advanced Solid Tumors Harboring RET Fusions or Mutations |
https://ClinicalTrials.gov/show/NCT04161391 |
Recruiting |
Turning Point Therapeutics, Inc. |
2024-05-31 |
| NCT02867592 |
Cabozantinib-S-Malate in Treating Younger Patients With Recurrent, Refractory, or Newly Diagnosed Sarcomas, Wilms Tumor, or Other Rare Tumors |
https://ClinicalTrials.gov/show/NCT02867592 |
Recruiting |
National Cancer Institute (NCI) |
2020-09-30 |
| NCT02568267 |
Basket Study of Entrectinib (RXDX-101) for the Treatment of Patients With Solid Tumors Harboring NTRK 1/2/3 (Trk A/B/C), ROS1, or ALK Gene Rearrangements (Fusions) |
https://ClinicalTrials.gov/show/NCT02568267 |
Recruiting |
Hoffmann-La Roche |
2022-12-01 |
| NCT03475953 |
A Phase I/II Study of Regorafenib Plus Avelumab in Solid Tumors |
https://ClinicalTrials.gov/show/NCT03475953 |
Recruiting |
Institut Bergonié |
2020-11-30 |
| NCT03246659 |
Radiolabelled CCK-2/Gastrin Receptor Analogue for Personalized Theranostic Strategy in Advanced MTC |
https://ClinicalTrials.gov/show/NCT03246659 |
Completed |
Azienda Ospedaliero, Universitaria Pisana |
2018-11-30 |
| NCT03239769 |
Compare the Aesthetic Effect of Different Thyroidectomies |
https://ClinicalTrials.gov/show/NCT03239769 |
Completed |
Beijing Cancer Hospital |
2015-06-01 |
| NCT02702388 |
A Phase 2 Trial of Lenvatinib (E7080) in Subjects With Iodine-131 Refractory Differentiated Thyroid Cancer to Evaluate Whether an Oral Starting Dose of 18 mg Daily Will Provide Comparable Efficacy to a 24 mg Starting Dose, But Have a Better Safety Profile |
https://ClinicalTrials.gov/show/NCT02702388 |
Active, not recruiting |
Eisai Inc. |
2019-12-12 |
| NCT03866382 |
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors |
https://ClinicalTrials.gov/show/NCT03866382 |
Recruiting |
National Cancer Institute (NCI) |
2023-02-28 |
| NCT02432274 |
Study of Lenvatinib in Children and Adolescents With Refractory or Relapsed Solid Malignancies and Young Adults With Osteosarcoma |
https://ClinicalTrials.gov/show/NCT02432274 |
Completed |
Eisai Inc. |
2019-07-31 |
| NCT03157128 |
Phase 1/2 Study of LOXO-292 in Patients With Advanced Solid Tumors, RET Fusion-Positive Solid Tumors, and Medullary Thyroid Cancer |
https://ClinicalTrials.gov/show/NCT03157128 |
Recruiting |
Loxo Oncology, Inc. |
2022-03-31 |
| NCT04137185 |
Clinical Study of rhTSH in the Treatment of Patients With Thyroid Cancer After Resection of Stage I/II |
https://ClinicalTrials.gov/show/NCT04137185 |
Recruiting |
Suzhou Zelgen Biopharmaceuticals Co.,Ltd |
2020-06-30 |
| NCT03669432 |
To Study the Impact of Radiation Treatment After Surgery in Patient With Locally Advanced Thyroid Cancer. |
https://ClinicalTrials.gov/show/NCT03669432 |
Recruiting |
Tata Memorial Hospital |
2021-07-31 |
| NCT00794053 |
The Usefulness of Staining Lymph Nodes During Operations for Cancer Thyroid in Detecting the Nodes That Have Cancer |
https://ClinicalTrials.gov/show/NCT00794053 |
Completed |
University of Alexandria |
2008-12-31 |
| NCT00784303 |
Evaluating the Safety and Efficacy of Oral Lenvatinib in Medullary and Iodine-131 Refractory, Unresectable Differentiated Thyroid Cancers, Stratified by Histology |
https://ClinicalTrials.gov/show/NCT00784303 |
Completed |
Eisai Inc. |
2011-04-11 |
| NCT00754182 |
Subcuticular Suture Versus Synthetic Glue in Thyroidectomy Incision |
https://ClinicalTrials.gov/show/NCT00754182 |
Completed |
Azienda Ospedaliero-Universitaria di Modena |
2010-05-31 |
| NCT00729157 |
Aflibercept in Treating Patients With Recurrent and/or Metastatic Thyroid Cancer That Did Not Respond to Radioactive Iodine Therapy |
https://ClinicalTrials.gov/show/NCT00729157 |
Completed |
National Cancer Institute (NCI) |
2012-10-31 |
| NCT00718770 |
A Pilot Clinical Trial for Poorly Differentiated Thyroid Cancer - Correlation to Retinoid and Peroxisome-proliferator-activated Receptor (PPARy) Expression |
https://ClinicalTrials.gov/show/NCT00718770 |
Completed |
University of Colorado, Denver |
2013-01-31 |
| NCT00704730 |
Efficacy of XL184 (Cabozantinib) in Advanced Medullary Thyroid Cancer |
https://ClinicalTrials.gov/show/NCT00704730 |
Active, not recruiting |
Exelixis |
2011-10-31 |
| NCT00673010 |
Lesion Dosimetry With 124-Iodine in Metastatic Thyroid Carcinoma |
https://ClinicalTrials.gov/show/NCT00673010 |
Active, not recruiting |
Memorial Sloan Kettering Cancer Center |
2021-03-31 |
| NCT00668811 |
Sutent Adjunctive Treatment of Differentiated Thyroid Cancer |
https://ClinicalTrials.gov/show/NCT00668811 |
Completed |
Washington Hospital Center |
2015-09-30 |
| NCT00654238 |
Phase II Trial of Sorafenib (Nexavar) in Patients With Advanced Thyroid Cancer |
https://ClinicalTrials.gov/show/NCT00654238 |
Completed |
University of Pennsylvania |
2010-12-31 |
| NCT00625846 |
Pazopanib Hydrochloride in Treating Patients With Advanced Thyroid Cancer |
https://ClinicalTrials.gov/show/NCT00625846 |
Completed |
National Cancer Institute (NCI) |
2018-12-21 |
| NCT00615537 |
Pilot Study on Laser Ablation of Symptomatic Benign Thyroid Masses |
https://ClinicalTrials.gov/show/NCT00615537 |
Completed |
BioTex, Inc. |
2011-01-31 |
| NCT00604318 |
Quality of Life, Recombinant TSH (Thyrogen) and Thyroid Cancer |
https://ClinicalTrials.gov/show/NCT00604318 |
Completed |
Copenhagen University Hospital at Herlev |
2012-02-29 |
| NCT00603941 |
A Phase 1/2 Dose Finding Study of an Experimental New Drug CS7017, an Oral PPARγ Agonist Taken by Mouth Twice Daily in Combination With Paclitaxel Chemotherapy |
https://ClinicalTrials.gov/show/NCT00603941 |
Completed |
Daiichi Sankyo, Inc. |
2011-12-31 |
| NCT00559949 |
Selumetinib in Treating Patients With Papillary Thyroid Cancer That Did Not Respond to Radioactive Iodine |
https://ClinicalTrials.gov/show/NCT00559949 |
Completed |
National Cancer Institute (NCI) |
2016-08-31 |
| NCT00537797 |
Accuracy of FDG-PET Scanning to Diagnose Malignant Thyroid Nodules |
https://ClinicalTrials.gov/show/NCT00537797 |
Completed |
Washington University School of Medicine |
2011-09-30 |
| NCT00537095 |
Efficacy and Safety of Vandetanib (ZD6474) in Patients With Metastatic Papillary or Follicular Thyroid Cancer |
https://ClinicalTrials.gov/show/NCT00537095 |
Active, not recruiting |
Sanofi |
2009-12-31 |
| NCT00519896 |
Sunitinib Malate in Treating Patients With Iodine-Refractory Recurrent or Metastatic Thyroid Cancer |
https://ClinicalTrials.gov/show/NCT00519896 |
Completed |
University of Washington |
2015-05-31 |
| NCT00514046 |
Vandetanib to Treat Children and Adolescents With Medullary Thyroid Cancer |
https://ClinicalTrials.gov/show/NCT00514046 |
Active, not recruiting |
National Institutes of Health Clinical Center (CC) |
2019-12-10 |
| NCT00510640 |
Thyroid Cancer and Sunitinib |
https://ClinicalTrials.gov/show/NCT00510640 |
Completed |
University Hospital, Bordeaux |
2012-03-31 |
| NCT00470496 |
Photodynamic Therapy Using HPPH in Treating Patients Undergoing Surgery for Primary or Recurrent Head and Neck Cancer |
https://ClinicalTrials.gov/show/NCT00470496 |
Completed |
Roswell Park Cancer Institute |
2011-10-28 |
| NCT00467506 |
Phase II Two-step Radioimmunotherapy Clinical Study in Medullary Thyroid Carcinoma |
https://ClinicalTrials.gov/show/NCT00467506 |
Completed |
Nantes University Hospital |
2011-01-31 |
| NCT00451880 |
Study of XL281 in Adults With Solid Tumors |
https://ClinicalTrials.gov/show/NCT00451880 |
Completed |
Exelixis |
2011-10-31 |
| NCT00415233 |
High Dose vs Low Dose I 131 +/- rhTSH for Differentiated Thyroid Cancer |
https://ClinicalTrials.gov/show/NCT00415233 |
Active, not recruiting |
University College, London |
2011-06-30 |
| NCT00410761 |
An Efficacy Study Comparing ZD6474 to Placebo in Medullary Thyroid Cancer |
https://ClinicalTrials.gov/show/NCT00410761 |
Active, not recruiting |
Sanofi |
2009-07-31 |
| NCT00405405 |
Phase I of Biologics and Chemoradiation Therapy for Advanced Head and Neck Cancer |
https://ClinicalTrials.gov/show/NCT00405405 |
Completed |
Thomas Jefferson University |
2010-06-30 |
| NCT00400465 |
Is the Routine Pressure Dressing After Thyroidectomy Necessary? |
https://ClinicalTrials.gov/show/NCT00400465 |
Completed |
Khon Kaen University |
2007-08-31 |
| NCT00390325 |
Sorafenib Tosylate in Treating Patients With Metastatic, Locally Advanced, or Recurrent Medullary Thyroid Cancer |
https://ClinicalTrials.gov/show/NCT00390325 |
Active, not recruiting |
National Cancer Institute (NCI) |
2017-01-30 |
| NCT00389441 |
Study Of AG-013736 In Patients With 131I-Refractory Thyroid Cancer |
https://ClinicalTrials.gov/show/NCT00389441 |
Completed |
Pfizer |
2012-09-30 |
| NCT00381641 |
Sunitinib Malate in Treating Patients With Thyroid Cancer That Did Not Respond to Iodine I 131 and Cannot Be Removed by Surgery |
https://ClinicalTrials.gov/show/NCT00381641 |
Active, not recruiting |
National Cancer Institute (NCI) |
2016-12-31 |
| NCT00358956 |
A Study To Assess ZD6474 (ZACTIMAâ„¢) Monotherapy In Locally Advanced or Metastatic Hereditary Medullary Thyroid Cancer |
https://ClinicalTrials.gov/show/NCT00358956 |
Completed |
Sanofi |
2008-01-31 |
| NCT00295763 |
A New Study to Follow-up Thyroid Cancer Patients Who Participated in a Previous Study, Which Compared the Success of Destruction of the Thyroid Remnant Using Standard Treatment or Thyrogen. |
https://ClinicalTrials.gov/show/NCT00295763 |
Completed |
Sanofi |
2006-07-31 |
| NCT00287287 |
REVLIMID® (Lenalidomide) for Therapy of Radioiodine-Unresponsive Papillary and Follicular Thyroid Carcinomas |
https://ClinicalTrials.gov/show/NCT00287287 |
Completed |
University of Kentucky |
2010-07-06 |
| NCT00279721 |
Phase II Study of IMRT With SIB as Adjuvant Treatment for High Risk Resected Well-differentiated Thyroid Cancer. |
https://ClinicalTrials.gov/show/NCT00279721 |
Completed |
AHS Cancer Control Alberta |
2010-06-30 |
| NCT00251316 |
Effect of Lithium Carbonate on Low-Dose Radioiodine Therapy in Early Thyroid Cancer |
https://ClinicalTrials.gov/show/NCT00251316 |
Completed |
National Institutes of Health Clinical Center (CC) |
2011-12-31 |
| NCT00223158 |
Evaluation Study of L-T3 Utility in the Follow-up of Patients With Thyroid Cancer |
https://ClinicalTrials.gov/show/NCT00223158 |
Completed |
Université de Sherbrooke |
2005-05-31 |
| NCT00215605 |
Study of XL184 (Cabozantinib) in Adults With Advanced Malignancies |
https://ClinicalTrials.gov/show/NCT00215605 |
Completed |
Exelixis |
2011-04-30 |
| NCT00196729 |
Comparison of the Safety and Successful Ablation of Thyroid Remnant in Post-thyroidectomized Euthyroid Patients (i.e. Patients Administered Thyrogen) Versus Hypothyroid Patients (no Thyrogen) Following 131I Administration |
https://ClinicalTrials.gov/show/NCT00196729 |
Completed |
Sanofi |
NA |
| NCT00181168 |
Recombinant Thyrotropin PET-CT Fusion Scanning in Thyroid Cancer |
https://ClinicalTrials.gov/show/NCT00181168 |
Completed |
Johns Hopkins University |
2003-09-30 |
| NCT00176748 |
Treatment for Patients With Metastatic Thyroid Cancer |
https://ClinicalTrials.gov/show/NCT00176748 |
Completed |
University of Michigan Rogel Cancer Center |
2006-08-31 |
| NCT00144079 |
Multicenter Study Differentiated Thyroid Carcinoma |
https://ClinicalTrials.gov/show/NCT00144079 |
Completed |
University Hospital Muenster |
NA |
| NCT00134043 |
Suberoylanilide Hydroxamic Acid in Treating Patients With Metastatic and/or Locally Advanced or Locally Recurrent Thyroid Cancer |
https://ClinicalTrials.gov/show/NCT00134043 |
Completed |
National Cancer Institute (NCI) |
2009-03-31 |
| NCT00124527 |
Study of Irofulven Plus Capecitabine in Patients With Advanced Thyroid Cancer |
https://ClinicalTrials.gov/show/NCT00124527 |
Completed |
Eisai Inc. |
NA |
| NCT00123760 |
Study of 18F-Fluorodeoxyglucose (FluGlucoScan) in Patients With Cancer or Suspected Cancer |
https://ClinicalTrials.gov/show/NCT00123760 |
Completed |
AHS Cancer Control Alberta |
2008-12-31 |
| NCT00121628 |
A Phase 2, Open-label Study of AMG 706 to Treat Subjects With Locally Advanced or Metastatic Thyroid Cancer |
https://ClinicalTrials.gov/show/NCT00121628 |
Completed |
Amgen |
2006-11-30 |
| NCT00118248 |
Tanespimycin in Treating Patients With Inoperable Locoregionally Advanced or Metastatic Thyroid Cancer |
https://ClinicalTrials.gov/show/NCT00118248 |
Completed |
National Cancer Institute (NCI) |
2009-08-31 |
| NCT00115895 |
The Dose of Radioactive Iodine Needed to Ablate the Thyroid Remnant Left Behind After Thyroidectomy |
https://ClinicalTrials.gov/show/NCT00115895 |
Active, not recruiting |
University of Helsinki |
2004-10-31 |
| NCT00104871 |
Bortezomib in Treating Patients With Metastatic Thyroid Cancer That Did Not Respond to Radioactive Iodine Therapy |
https://ClinicalTrials.gov/show/NCT00104871 |
Completed |
National Cancer Institute (NCI) |
2010-05-31 |
| NCT00098813 |
Romidepsin in Treating Patients With Recurrent and/or Metastatic Thyroid Cancer That Has Not Responded to Radioactive Iodine |
https://ClinicalTrials.gov/show/NCT00098813 |
Completed |
National Cancer Institute (NCI) |
2009-08-31 |
| NCT00098345 |
Efficacy and Tolerability of ZD6474 in Patients With Thyroid Cancer |
https://ClinicalTrials.gov/show/NCT00098345 |
Completed |
Sanofi |
2008-02-29 |
| NCT00095836 |
Gefitinib in Treating Patients With Locally Advanced or Metastatic Thyroid Cancer That Did Not Respond to Iodine Therapy |
https://ClinicalTrials.gov/show/NCT00095836 |
Completed |
Massachusetts General Hospital |
2011-03-31 |
| NCT00094055 |
Study of the Anti-angiogenesis Agent AG-013736 in Patients With Metastatic Thyroid Cancer |
https://ClinicalTrials.gov/show/NCT00094055 |
Completed |
Pfizer |
2009-01-31 |
| NCT00004089 |
Chemotherapy Plus Radiation Therapy in Treating Patients With Previously Untreated Thyroid Cancer |
https://ClinicalTrials.gov/show/NCT00004089 |
Completed |
National Cancer Institute (NCI) |
2002-04-30 |
| NCT00085293 |
Decitabine in Treating Patients With Metastatic Papillary Thyroid Cancer or Follicular Thyroid Cancer Unresponsive to Iodine I 131 |
https://ClinicalTrials.gov/show/NCT00085293 |
Completed |
National Cancer Institute (NCI) |
2014-01-31 |
| NCT00004048 |
Radioimmunotherapy With or Without Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Thyroid Cancer |
https://ClinicalTrials.gov/show/NCT00004048 |
Completed |
Garden State Cancer Center at the Center for Molecular Medicine and Immunology |
2002-05-31 |
| NCT00080574 |
The Effect of Thyroid Hormone on Drug Elimination in Cancer Patients |
https://ClinicalTrials.gov/show/NCT00080574 |
Completed |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT00004074 |
Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/Neu |
https://ClinicalTrials.gov/show/NCT00004074 |
Completed |
National Cancer Institute (NCI) |
2009-02-28 |
| NCT00068497 |
Gefitinib in Treating Patients With Metastatic or Unresectable Head and Neck Cancer or Non-Small Cell Lung Cancer |
https://ClinicalTrials.gov/show/NCT00068497 |
Completed |
National Cancer Institute (NCI) |
2007-12-31 |
| NCT00795782 |
Prophylactic Central Lymph Node Dissection in Papillary Thyroid Microcarcinoma |
https://ClinicalTrials.gov/show/NCT00795782 |
Completed |
Samsung Medical Center |
2012-06-30 |
| NCT00001730 |
Study of Radioiodine (131-I) Uptake Following Administration of Thyrogen and Hypothyroid States During Thyroid Hormone Withdrawal. |
https://ClinicalTrials.gov/show/NCT00001730 |
Completed |
National Institutes of Health Clinical Center (CC) |
NA |